Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/28/2026, 1:22:44 AM
    Content snapshot
    {
      "session_id": "sess_db9a224d-3ebb-429c-8f02-b703d71ca211_task_66f1207e_recon",
      "round_number": 4,
      "agent_persona": "persona-synthesizer",
      "agent_backend": "scidex.core.llm.complete",
      "action": "synthesize",
      "content": "{\n  \"ranked_hypotheses\": [\n    {\n      \"title\": \"APOE \\u03b54-driven microglial lipid handling as proximal driver in Non-Neuronal Transcriptional Changes Preceding Tau Propagation as Early AD Biomarkers\",\n      \"description\": \"APOE \\u03b54-driven microglial lipid handling should produce a measurable proximal phenotype before late disease pathology. The decisive test is isogenic APOE3/APOE4 microglia co-cultured with amyloid-bearing neurons, lipidomics, and phagocytosis/degradation assays.\",\n      \"target_gene\": \"RNA-\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.62,\n        \"novelty\": 0.72,\n        \"feasibility\": 0.67,\n        \"therapeutic_potential\": 0.64,\n        \"mechanistic_plausibility\": 0.7,\n        \"druggability\": 0.54,\n        \"safety_profile\": 0.52,\n        \"competitive_landscape\": 0.58,\n        \"data_availability\": 0.66,\n        \"reproducibility\": 0.61\n      },\n      \"composite_score\": 0.626,\n      \"evidence_for\": [\n        {\n          \"claim\": \"Spatial transcriptomics identified non-neuronal dysregulation patterns in AD; the temporal ordering of non-neuronal changes relative to tau spread was identified as a key open question.\",\n          \"doi\": \"10.1038/s41380-024-02651-0\",\n          \"source\": \"Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal cell types in Alzheimer's disease\"\n        }\n      ],\n      \"evidence_against\": [\n        {\n          \"claim\": \"lipid droplet accumulation may be compensatory rather than causal, and bulk amyloid readouts can miss subpopulation-specific effects\",\n          \"doi\": \"10.1038/s41380-024-02651-0\",\n          \"source\": \"Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal cell types in Alzheimer's disease\"\n        }\n      ]\n    },\n    {\n      \"title\": \"Cell-state stratification is required to resolve Non-Neuronal Transcriptional Changes Preceding Tau Propagation as Early AD Biomarkers\",\n      \"description\": \"The question is likely underpowered or misleading unless analyses preserve the key strata: RNA-, APOE. Averaging across these strata could convert a causal subpopulation effect into a weak association.\",\n      \"target_gene\": \"APOE\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.58,\n        \"novelty\": 0.64,\n        \"feasibility\": 0.73,\n        \"therapeutic_potential\": 0.55,\n        \"mechanistic_plausibility\": 0.65,\n        \"druggability\": 0.45,\n        \"safety_profile\": 0.62,\n        \"competitive_landscape\": 0.56,\n        \"data_availability\": 0.7,\n        \"reproducibility\": 0.64\n      },\n      \"composite_score\": 0.612,\n      \"evidence_for\": [\n        {\n          \"claim\": \"The open question explicitly depends on cell-type, region, or molecular-state resolution.\",\n          \"doi\": \"10.1038/s41380-024-02651-0\"\n        }\n      ],\n      \"evidence_against\": [\n        {\n          \"claim\": \"Stratified effects may reflect sampling or annotation artifacts rather than mechanism.\",\n          \"doi\": \"10.1038/s41380-024-02651-0\"\n        }\n      ]\n    },\n    {\n      \"title\": \"Perturbation-first validation should precede therapeutic claims for Non-Neuronal Transcriptional Changes Preceding Tau Propagation as Early AD Biomarkers\",\n      \"description\": \"The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.\",\n      \"target_gene\": \"\",\n      \"dimension_scores\": {\n        \"evidence_strength\": 0.55,\n        \"novelty\": 0.6,\n        \"feasibility\": 0.76,\n        \"therapeutic_potential\": 0.57,\n        \"mechanistic_plausibility\": 0.63,\n        \"druggability\": 0.48,\n        \"safety_profile\": 0.6,\n        \"competitive_landscape\": 0.55,\n        \"data_availability\": 0.68,\n        \"reproducibility\": 0.66\n      },\n      \"composite_score\": 0.608,\n      \"evidence_for\": [\n        {\n          \"claim\": \"The proposed priority experiment is concrete: isogenic APOE3/APOE4 microglia co-cultured with amyloid-bearing neurons, lipidomics, and phagocytosis/degradation assays\",\n          \"doi\": \"10.1038/s41380-024-02651-0\"\n        }\n      ],\n      \"evidence_against\": [\n        {\n          \"claim\": \"Therapeutic tractability is not established by the current source evidence.\",\n          \"doi\": \"10.1038/s41380-024-02651-0\"\n        }\n      ]\n    }\n  ],\n  \"knowledge_edges\": [\n    {\n      \"source_id\": \"db9a224d-3ebb-429c-8f02-b703d71ca211\",\n      \"source_type\": \"analysis\",\n      \"target_id\": \"RNA-\",\n      \"target_type\": \"entity\",\n      \"relation\": \"debate_reconstructs_evidence_for\"\n    },\n    {\n      \"source_id\": \"db9a224d-3ebb-429c-8f02-b703d71ca211\",\n      \"source_type\": \"analysis\",\n      \"target_id\": \"APOE\",\n      \"target_type\": \"entity\",\n      \"relation\": \"debate_reconstructs_evidence_for\"\n    }\n  ],\n  \"synthesis_summary\": \"Consensus: Non-Neuronal Transcriptional Changes Preceding Tau Propagation as Early AD Biomarkers is a valid debate target because it is anchored to Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal cell types in Alzheimer's disease and asks a falsifiable question about APOE \\u03b54-driven microglial lipid handling. Dissent: the source evidence does not yet prove causality, and lipid droplet accumulation may be compensatory rather than causal, and bulk amyloid readouts can miss subpopulation-specific effects. The next step is isogenic APOE3/APOE4 microglia co-cultured with amyloid-bearing neurons, lipidomics, and phagocytosis/degradation assays.\"\n}",
      "tokens_used": "1391",
      "persona_id": "persona-synthesizer"
    }